Search Results

Site Search

Interpretation of qualitative and quantitative urine opiate tests for pain management patients - Insights

In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the use of qualitative urine screening assays and quantitative confirmatory testing to determine compliance in pain management patients.

connective_tissue_disease_cascade.pdf

01/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Connective Tissue Disease Cascade ≥20 U <20 U CTDC / Connective Tissue Diseases Cascade, Serum Cyclic citrullinated peptide antibodies,...

What's New in Health Care Reform: Feb. 13 - Insights

Top highlights include: College education doesn't protect against Alzheimer's, A.I. shows promise as a physician assistant, how machine learning is crafting precision medicine, CVS introduces new concept store with more health care, and...

international-shipping-guide.pdf

IN TERN ATIO N AL SH IPPIN G G U ID ESEND TESTING TO MAYO CLINIC FROM AROUND THE WORLD 2 | INTERNATIONAL SHIPPING GUIDE UNITED STATES SHIPPING GUIDE | 2 TABLE OF CONTENTS SHIP TO US FROM AROUND THE WORLD 3 Prior to...

Seeking, and finding, answers, comfort, and hope: Joe Mondloch - Insights

Joe Mondloch and his wife Sue have existed in a grey area of uncertainty due to the unpredictable autoimmune neurological illness Joe has lived with for the last seven years. Rare, incurable, and debilitating, the newly classified disorder...

MASTERMIND: A Smarter Search for Microbial Diagnostics - Insights

In the war against microbes, human beings are vastly outnumbered—and losing the weapons race.

New tests launched in October - Insights

In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

It Remains Unknown: Link between Gadolinium Exposure via MRI Exams and Health Effects in Patients with Normal Renal Function - Insights

There have been concerns in the U.S. recently about the possible harmful side effects from absorbing gadolinium-based contrast agents into the body during some MRI exams. To address some of the anxiety and concerns over this issue, Paul...

search - Mayo Clinic Laboratories

Search Results Site Search...

New Year's Specimen Shipping Guidelines and Schedule - Insights

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered for the New Year's holiday. To ensure specimen viability and minimize delays, the following adjustments and guidelines have been implemented and will be...

Diagnostic ecosystem boosts access to timely Alzheimer's disease testing - Insights

Mayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer's disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The testing suite exemplifies Mayo Clinic...

Genetics - Mayo Clinic Laboratories

Our genetic testing was developed by experienced geneticists, genetic counselors, laboratory scientists, and bioinformaticians. We focus on providing easy to understand answers, interpreted by those same individuals who have an intimate...

About Us - Insights

Mayo Clinic Laboratories isn’t just a reference lab. We’re also the diagnostic lab for a hospital, just like your lab. So we know the many benefits of keeping tests as close to patients as possible.

Every test tube connects to a patient: Quality control of specimens in the pre-analytic phase - Insights

Each day, some 40 to 45 thousand specimens are shipped to Mayo Clinic Laboratories in Rochester, Minnesota, from hospitals and other health care organizations around the world. And for every sample, there’s a patient to whom it belongs,...

A comprehensive test menu explores genome for druggable targets to treat gastrointestinal cancers - Insights

Since 1992, cases of colorectal cancer have been on a slow decline, yet 52,550 people died from it in 2023. At Mayo Clinic, a cutting-edge menu of both germline (inherited genetic alterations) and somatic (tumors due to non-inherited...

A "sandbox" for innovation: The Advanced Diagnostics Laboratory - Insights

Mayo Clinic’s Advanced Diagnostics Laboratory (ADL) is a visionary space designed to foster innovation. The ADL has a direct impact on patient lives, bringing promising tests and services to patients at Mayo and around the world.

autoimmune-paraneoplastic-axonal-neuropathy-evaluation-algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Autoimmune/Paraneoplastic Axonal Neuropathy Evaluation Algorithm ■ AGNA immunoblot ■ AGNA IFA Titer ■ GFAP antibody CBA ■ GFAP antibody IFA...

hepatitisbtesting-algorithmforscreeningdiagnosismanagement.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2024 Result Profile Table Test ID Test Name HBs antigen HBs antibody (Ab) HBc total Ab HBc IgM Ab HBe antigen HBe Ab HAV total Ab HAV IgM Ab HCV...

RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D. - Insights

Lisa Rimsza, M.D., explains how Mayo Clinic Laboratories' unique PM3CX test can accurately determine subtypes of large B-cell lymphoma. Precise diagnosis is critical to choosing appropriate chemotherapy.

Classical Hematology 2023 - Insights

This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....

Classical Hematology 2023 - Insights

This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....

Classical Hematology 2023 - Insights

This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....

Classical Hematology 2023 - Insights

This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....

Classical Hematology 2023 - Insights

This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....

Classical Hematology 2023 - Insights

This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....

Classical Hematology 2023 - Insights

This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....

Classical Hematology 2023 - Insights

This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....

Classical Hematology 2023 - Insights

This Mayo Clinic conference will address the approach to the evaluation of frequently encountered blood count abnormalities. It will also provide an update on the diagnosis and management of common and rare nonmalignant blood disorders....

pathology_consultation_ordering_algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2025 Pathology Consultation Ordering Algorithm When requesting a Pathology Consultation, the test order is based on the specimen type as follows: Slides...

Intestinal Infection Testing - Mayo Clinic Laboratories

The gastrointestinal pathogen panel is a multiplex polymerase chain reaction (PCR) test capable of rapidly and qualitatively detecting DNA or RNA of 22 pathogens (13 bacteria, 5 viruses, and 4 parasites).

New tests launched in February - Insights

In February 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights

In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...

New tests launched in January - Insights

In January 2023, Mayo Clinic Laboratories announced fifty-nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

TRBC1 a Useful Tool in T-Cell Flow Cytometry [Test in Focus] - Insights

Horatiu Olteanu, M.D., Ph.D., gives an overview of the updated Leukemia and Lymphoma Immunophentoyping test now including TCRBC1 available through Mayo Clinic Laboratories.

testing_algorithm_for_the_screening_and_diagnosis_of_hepatitis_c.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 02/2022 Hepatitis C: Testing Algorithm for Screening and Diagnosis HCVQN / Hepatitis C Virus (HCV) RNA Detection and Quantification by Real-Time Reverse...

lysosomal-disorders-diagnostic-algorithm-part2.pdf

If deficient, MLD confirmed One of the following suspected: ■ Aspartylglucosaminuria ■ α-Mannosidosis ■ β-Mannosidosis ■ Pompe disease ■ Sandhoff disease ■ Schindler disease ■ Sialidosis1 ■ Galactosialidosis1,2 ■ α-Fucosidosis2 ■...

The Prostate Health Index (PHI) in Prostate Cancer Risk Assessment - Insights

In this month’s “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., will provide you with valuable information regarding the utility of the prostate specific antigen test, and how the calculation of a prostate health index, or phi, can help to...

MDM2 gene amplification [Test in Focus] - Insights

William Sukov, M.D., provides an overview of the MDM2 gene amplification assay — a test that looks for amplification of the MDM2 gene region on chromosome 12q. He reviews when this test should be ordered, how it compares to other test...

Weeding Through the Information: Interpreting Laboratory Tests to Determine New vs. Residual Use of Marijuana - Insights

In this month's "Hot Topic," Paul Jannetto, Ph.D., identifies how to determine new vs. residual use of marijuana in a patient, and teaches how to calculate the carboxy-tetrahydrocannabinol (carboxy-THC) to creatinine ratio along with a...

Preeclampsia - Insights

Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.

West Nile virus [Test in Focus] - Insights

Bobbi Pritt, M.D., discusses how Mayo Clinic Labs’ updated PCR assay for West Nile virus provides increased sensitivity to detect virus RNA in multiple sources, identifies two virus lineages, and confirms diagnosis.

MayoComplete - Insights

Find out how our suite of MayoComplete next-generation sequencing panels puts patients on the right treatment path.

MCL - Stool Collection Instructions - MC5424-21

MCL - Stool Collection Instructions - PATIENT EDUCATION Stool Collection Instructions read material start stool collection Collect stool

Urinary stone services - Insights

Learn how our approach to kidney stone services and concise reporting enable accurate interpretation to guide clinical decisions.

Prostate Health Index (phi) [Test in Focus] - Insights

Useful For Assessing the patient’s probability of having detectable prostate cancer when totalprostate specific antigen (PSA) concentrations are between

Breast Pathology Services at Mayo Clinic Laboratories

Given our case volume, we've developed a special expertise in those rare variants of carcinoma, where the diagnosis is essential. Learn more.

https://news.mayocliniclabs.com/file-activity-metrics-user-guide/

Activity Metrics User’s Guide Release 1.21 Page 2 9/26/24 Activity Metrics User’s Guide TABLE OF CONTENTS Introduction...

Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights

In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.

Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights

In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.

CPT Codes and LOINC Update: June 2020 - Insights

View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of June.